Your browser doesn't support javascript.
loading
Fulranumab for treatment of diabetic peripheral neuropathic pain: A randomized controlled trial.
Wang, Hao; Romano, Gary; Frustaci, Mary Ellen; Bohidar, Norm; Ma, Huizhong; Sanga, Panna; Ness, Seth; Russell, Lucille J; Fedgchin, Margaret; Kelly, Kathleen M; Thipphawong, John.
Afiliação
  • Wang H; From the National Institute of Neurological Disorders and Stroke (H.W.), Bethesda, MD; and Janssen Research & Development, LLC (G.R., M.E.F., N.B., H.M., P.S., S.N., L.J.R., M.F., K.M.K., J.T.), NJ. wangh16@ninds.nih.gov.
  • Romano G; From the National Institute of Neurological Disorders and Stroke (H.W.), Bethesda, MD; and Janssen Research & Development, LLC (G.R., M.E.F., N.B., H.M., P.S., S.N., L.J.R., M.F., K.M.K., J.T.), NJ.
  • Frustaci ME; From the National Institute of Neurological Disorders and Stroke (H.W.), Bethesda, MD; and Janssen Research & Development, LLC (G.R., M.E.F., N.B., H.M., P.S., S.N., L.J.R., M.F., K.M.K., J.T.), NJ.
  • Bohidar N; From the National Institute of Neurological Disorders and Stroke (H.W.), Bethesda, MD; and Janssen Research & Development, LLC (G.R., M.E.F., N.B., H.M., P.S., S.N., L.J.R., M.F., K.M.K., J.T.), NJ.
  • Ma H; From the National Institute of Neurological Disorders and Stroke (H.W.), Bethesda, MD; and Janssen Research & Development, LLC (G.R., M.E.F., N.B., H.M., P.S., S.N., L.J.R., M.F., K.M.K., J.T.), NJ.
  • Sanga P; From the National Institute of Neurological Disorders and Stroke (H.W.), Bethesda, MD; and Janssen Research & Development, LLC (G.R., M.E.F., N.B., H.M., P.S., S.N., L.J.R., M.F., K.M.K., J.T.), NJ.
  • Ness S; From the National Institute of Neurological Disorders and Stroke (H.W.), Bethesda, MD; and Janssen Research & Development, LLC (G.R., M.E.F., N.B., H.M., P.S., S.N., L.J.R., M.F., K.M.K., J.T.), NJ.
  • Russell LJ; From the National Institute of Neurological Disorders and Stroke (H.W.), Bethesda, MD; and Janssen Research & Development, LLC (G.R., M.E.F., N.B., H.M., P.S., S.N., L.J.R., M.F., K.M.K., J.T.), NJ.
  • Fedgchin M; From the National Institute of Neurological Disorders and Stroke (H.W.), Bethesda, MD; and Janssen Research & Development, LLC (G.R., M.E.F., N.B., H.M., P.S., S.N., L.J.R., M.F., K.M.K., J.T.), NJ.
  • Kelly KM; From the National Institute of Neurological Disorders and Stroke (H.W.), Bethesda, MD; and Janssen Research & Development, LLC (G.R., M.E.F., N.B., H.M., P.S., S.N., L.J.R., M.F., K.M.K., J.T.), NJ.
  • Thipphawong J; From the National Institute of Neurological Disorders and Stroke (H.W.), Bethesda, MD; and Janssen Research & Development, LLC (G.R., M.E.F., N.B., H.M., P.S., S.N., L.J.R., M.F., K.M.K., J.T.), NJ.
Neurology ; 83(7): 628-37, 2014 Aug 12.
Article em En | MEDLINE | ID: mdl-25008392
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuropatias Diabéticas / Fatores Imunológicos / Anticorpos Monoclonais / Neuralgia Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuropatias Diabéticas / Fatores Imunológicos / Anticorpos Monoclonais / Neuralgia Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article